High Court Won't Hear Novartis Appeal Of Zometa Suit
The U.S. Supreme Court refused Tuesday to take up Novartis Pharmaceuticals Corp.'s appeal of a state court ruling in a suit over its osteoporosis treatment drug Zometa, leaving the company on...To view the full article, register now.
Already a subscriber? Click here to view full article